Singh R, Lange S A
Acta Neurochir (Wien). 1975;32(1-2):125-30. doi: 10.1007/BF01405909.
Report of a series of 18 late secondary nerve grafts using lyophilised (disantigenised and disenzymatised) homografts of the Braun Melsungen Company. In contrast to the publication of Kuhlendahl et al. (1972) 32% of the cases showed definitive signs of regeneration. Therefore, in spite of the fact that autografts give better results, further research into the possibilities of homografts seems desirable. Their potential usefulness obviously is restricted to cases in which from any reasons autologous nerve grafts are not available.
关于使用布劳恩·梅尔松根公司冻干（去抗原和去酶）同种异体移植物进行的18例晚期二期神经移植的报告。与库伦达尔等人（1972年）的出版物相比，32%的病例显示出明确的再生迹象。因此，尽管自体移植效果更好，但对同种异体移植的可能性进行进一步研究似乎是可取的。它们的潜在用途显然仅限于因任何原因无法获得自体神经移植物的情况。
